Clinical TrialID 1602

Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics

NCT00992667

Bronchial Asthma

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
1602
Evidence Id
1602
Core Evidence Id
1602
Source Clinical Trial Id
1576
Herb2 Clinical Trial Id
HBCT001576
Nct Id
NCT00992667
Title
Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Bronchial Asthma
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Apocynin nebulization
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult
Enrollment
10
Outcome Measure
blood pressure, peripheral blood differential count, lung functional tests, single breath carbon monoxide diffusing capacity, 6 months
Sponsor Collaborator
Medical University of Lodz|Ministry of Science and Higher Education, Poland
Funded By
OTHER
Location
Medical University of Lodz, Lodz, Lodzkie, 92-213, Poland
Other Id
Nowak-01
Start Date
2008-06
Primary Completion Date
2008-08
Completion Date
2008-11
First Posted
2009-10-09
Results First Posted
Last Update Posted
2009-10-09
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00992667
Title Cn
Title En
Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics
Bilingual Status
semi_complete